-
Article
A nine-gene signature predicting clinical outcome in cutaneous melanoma
Current histopathological staging of cutaneous melanoma is limited in predicting outcome, and complementary molecular markers are not available for prognostic assessment. The purpose of this study was to ident...
-
Article
Effect of two 5-HT6 receptor antagonists on the rat liver: a molecular approach
Serotonin is involved in disorders of the central nervous system; thus, specific 5-HT6 receptor antagonists have therapeutic potential. Nevertheless, preclinical tests showed that Ro 65-7199 caused hepatic steato...
-
Article
Expression of VLA-4 on primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels correlates with clinical outcome
-
Article
Late abstracts 186–187
-
Article
BCG immunotherapy in stage I melanoma patients
Previously, we have provided evidence for a positive correlation between HLA-DR expression in primary melanoma and early metastasis [3, 4]. In the present study we investigated whether this relationship was mo...
-
Article
Flow cytometric (FCM) studies on the biology of malignant melanomas and premalignant lesions
-
Article
Expression of class I and class II HLA antigens in primary and metastatic melanoma: Relation to prognosis
-
Chapter
Immunologische Aspekte maligner Melanome
Klinische und histologische Beobachtungen führten zu der Vorstellung, daß immunologische Vorgänge bei der Melanomerkrankung eine wichtige Rolle spielen.
-
Chapter
Cellular and Molecular Parameters of Tumor Progression in Human Malignant Melanoma
Human malignant melanoma is a spontaneous tumor, which progresses from the initial premalignant lesion to highly metastatic forms. Tumor progression seems to be a complex multistage process, during which sever...
